Soluble Guanylate Cyclase Stimulators in Heart Failure

被引：12
|
作者：
Kansakar, Sajog [1 ]
Guragain, Ashish [1 ]
Verma, Deepak [2 ]
Sharma, Prabhat [1 ,3 ]
Dhungana, Bibek [4 ]
Bhattarai, Bidit [5 ]
Yadav, Sunil [6 ]
Gautam, Ishant [7 ]
机构：
[1] Manipal Coll Med Sci, Internal Med, Pokhara, Nepal
[2] Calif Inst Behav Neurosci & Psychol, Internal Med Family Med, Fairfield, CA USA
[3] Shankarapur Hosp, Internal Med, Kathmandu, Nepal
[4] KIST Med Coll, Internal Med, Lalitpur, Nepal
[5] Venus Hosp, Internal Med, Kathmandu, Nepal
[6] Topa Primary Hlth Ctr, Internal Med, Rajbiraj, Nepal
[7] Bhaktapur Hosp, Internal Med, Bhaktapur, Nepal
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 09期
关键词：
heart failure with reduced ejection fraction (hfref); heart failure with preserved ejection fraction (hfpef); heart failure; guanylate cyclase stimulators; vericiguat; PRESERVED EJECTION FRACTION; NITRIC-OXIDE; VERICIGUAT; PATHOPHYSIOLOGY; CAPACITY; PLACEBO;
D O I：
10.7759/cureus.17781
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure has a high global burden of morbidity and mortality. Despite significant advances in medical management of heart failure, the prognosis remains poor. This justifies the search for newer therapeutic agents. Recently, soluble guanylate stimulators have demonstrated favorable results in clinical trials. This article aims to summarize the guanylate cyclase signaling pathway, the role of soluble guanylate cyclase stimulators in heart failure, and data from recent clinical trials of these drugs. We concluded that soluble guanylate cyclase stimulators have significant benefits in reducing hospitalizations in patients with heart failure with reduced ejection fraction that are at high risk of cardiovascular events. There appears to be no benefit of these drugs in patients with heart failure with preserved ejection fraction.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials
    Moghaddam, Nima
    Malhi, Navraj
    Toma, Mustafa
    AMERICAN HEART JOURNAL, 2021, 241 : 74 - 82
  • [32] Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction
    Mohamed T. Abuelazm
    Abdelrahman Attia
    Mohamed Abdelnabi
    Uzair Jafar
    Omar Almaadawy
    Mohamed A. Elzeftawy
    Abdelrahman Mahmoud
    Khaled Albakri
    Basel Abdelazeem
    The Egyptian Heart Journal, 76
  • [33] Safety And Effect on Mortality of Soluble Guanylate Cyclase Stimulators In Heart Failure Patients- A Systemic Review And Meta-analysis
    Asif, Anum
    Rawala, Muhammad Shabbir
    Ahmed, Faiza
    Shahatit, Rawan
    Aggarwal, Sandeep
    Siddiqui, Waqas Javed
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S39 - S39
  • [34] Soluble guanylate cyclase (sGC) stimulators as an emerging treatment for cardiopulmonary disease
    Follmann, Markus
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [35] Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
    Xiao, Sijia
    Li, Qianbin
    Hu, Liqing
    Yu, Zutao
    Yang, Jie
    Chang, Qi
    Chen, Zhuo
    Hu, Gaoyun
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (18) : 1544 - 1557
  • [36] Stimulators and Activators of Soluble Guanylate Cyclase: Review and Potential Therapeutic Indications
    Nossaman, Bobby
    Pankey, Edward
    Kadowitz, Philip
    CRITICAL CARE RESEARCH AND PRACTICE, 2012, 2012
  • [37] IMPACT OF ORAL SOLUBLE GUANYLATE CYCLASE STIMULATORS IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Moghaddam, Nima
    Malhi, Navraj
    Toma, Mustafa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 665 - 665
  • [38] CINACIGUAT, A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, UNLOADS THE HEART IN ACUTE DECOMPENSATED HEART FAILURE
    Erdmann, Erland
    Semigran, Marc J.
    Nieminen, Markku S.
    Agrawal, Rahul
    Mitrovic, Veselin
    Mebazaa, Alexandre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [39] Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure
    Campbell, Nicole
    Kalabalik-Hoganson, Julie
    Frey, Kathleen
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 600 - 608
  • [40] Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
    Pieske, Burkert
    Butler, Javed
    Filippatos, Gerasimos
    Lam, Carolyn
    Maggioni, Aldo Pietro
    Ponikowski, Piotr
    Shah, Sanjiv
    Solomon, Scott
    Kraigher-Krainer, Elisabeth
    Samano, Eliana Tibana
    Scalise, Andrea Viviana
    Mueller, Katharina
    Roessig, Lothar
    Gheorghiade, Mihai
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (09) : 1026 - 1038
12345